Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR AND A BCL-2 INHIBITOR
No-Receipt date
2021-04632 - 01/12/2021
No-Filing date
20210403189 - 01/12/2021
No-Granting date
3109087 - 15/12/2021
No-EPO application date
15757002.9 - 11/08/2015
No-EPO granting date
3179991 - 06/10/2021
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
12/2021 - 13/01/2022
Expiration date
12/08/2035
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US201462035795 P11/08/2014/US
US201462088240 P05/12/2014/US
US201562115497 P12/02/2015/US
US201562181160 P17/06/2015/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 45/06
A61K 39/395
A61K 31/675
A61K 31/519
A61K 31/4985
A61K 31/454
A61K 31/4468
A61K 31/437
A61K 31/416
A61K 31/4155
A61K 31/00
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1370761
ACERTA PHARMA B.V.
KLOOSTERSTRAAT 9
5349 AB OSS
NETHERLANDS
Inventors
Code
Firstname
Surname
3524028
HAMDY, AHMED
3524029
ROTHBAUM, WAYNE
3524030
IZUMI, RAQUEL
3524031
LANNUTTI, BRIAN
3524032
COVEY, TODD
3524033
ULRICH, ROGER
3524034
JOHNSON, DAVE
3524035
BARF, TJEERD
3524036
KAPTEIN, ALLARD
Representatives
Code
Firstname
Surname
Address
Town
Zip
3614
AIKATERINI
SIOTOU "KATERINA SIOTOU KAI SYNERGATES DIKIGORIKI ETAIREIA"
PATISION (28IS OKTOVRIOU) 122
ATHINA (ATTIKIS)
11257
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
4766
AIKATERINI
SIOTOU
PATISION (28IS OKTOVRIOU) 122
ATHINA (ATTIKIS)
11257
GREECE
Owners History
Title Instruments
Payments history
10 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).